Understanding how cancer drugs cause cell death
Characterization of drug mechanisms of lethality in vivo
This study is looking at how cancer drugs help kill tumor cells and aims to find out the different ways they do this, which could lead to better and more personalized treatments for cancer patients.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project ID | NIH-10952172 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which anti-cancer drugs induce cell death in tumors. It aims to identify the different pathways of cell death activated by these drugs, including both well-known and newly discovered forms of regulated necrosis. By developing a specialized tool to evaluate these mechanisms in living organisms, the research seeks to enhance our understanding of drug effectiveness and resistance. This could lead to more targeted and effective cancer treatments for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing treatment for various types of cancer who may benefit from new therapeutic strategies.
Not a fit: Patients with non-cancerous conditions or those who are not currently receiving anti-cancer treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer therapies that are more effective at killing cancer cells while minimizing resistance.
How similar studies have performed: Previous research has shown promise in understanding cell death mechanisms in cancer treatment, indicating that this approach could yield valuable insights.
Where this research is happening
Worcester, United States
- Univ of Massachusetts Med Sch Worcester — Worcester, United States (Active)
Researchers
- Principal investigator: Lee, Michael Jungho — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Lee, Michael Jungho
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.